Michael Kiefer1, Andreas Unterberg. 1. Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes, Kirrberger Str., 66421 Homburg, Germany.
Abstract
BACKGROUND: Normal-pressure hydrocephalus (NPH) arises in adulthood and is characterized by a typical combination of clinical and radiological findings. The mean basal intracranial pressure is normal or mildly elevated. The typical signs of the disease are gait impairment, urinary incontinence, and dementia. The difficulty of distinguishing NPH from other neurodegenerative disorders is the likely reason why some 80% of cases remain unrecognized and untreated. According to current evidence, the spontaneous course of NPH ends, for the vast majority of patients, in dependence on nursing care. METHODS: This review article is based on relevant publications retrieved by a selective search in Medline and on national and international guidelines for the management of NPH. RESULTS: Studies with a high evidence level are lacking; thus, the current state of knowledge about NPH is derived from studies of low or intermediate evidence levels, e.g., observational studies. Modern forms of treatment lead to clinical improvement in 70% to 90% of treated patients. The treatment of choice is the implantation of a ventriculoperitoneal shunt. The differential diagnosis is complicated by the fact that three-quarters of patients with NPH severe enough to require treatment also suffer from another neurodegenerative disorder. Therefore, the clinical findings and imaging studies often do not suffice to establish the indication for surgery. To do this, a further, semi-invasive diagnostic procedure is recommended. Current risk/benefit analyses indicate that shunt operations improve outcome compared to the spontaneous course of the disease. CONCLUSION: Normal pressure hydrocephalus should always enter into the differential diagnosis of patients who present with its characteristic manifestations. If the diagnosis of NPH is confirmed, it should be treated at an early stage.
BACKGROUND: Normal-pressure hydrocephalus (NPH) arises in adulthood and is characterized by a typical combination of clinical and radiological findings. The mean basal intracranial pressure is normal or mildly elevated. The typical signs of the disease are gait impairment, urinary incontinence, and dementia. The difficulty of distinguishing NPH from other neurodegenerative disorders is the likely reason why some 80% of cases remain unrecognized and untreated. According to current evidence, the spontaneous course of NPH ends, for the vast majority of patients, in dependence on nursing care. METHODS: This review article is based on relevant publications retrieved by a selective search in Medline and on national and international guidelines for the management of NPH. RESULTS: Studies with a high evidence level are lacking; thus, the current state of knowledge about NPH is derived from studies of low or intermediate evidence levels, e.g., observational studies. Modern forms of treatment lead to clinical improvement in 70% to 90% of treated patients. The treatment of choice is the implantation of a ventriculoperitoneal shunt. The differential diagnosis is complicated by the fact that three-quarters of patients with NPH severe enough to require treatment also suffer from another neurodegenerative disorder. Therefore, the clinical findings and imaging studies often do not suffice to establish the indication for surgery. To do this, a further, semi-invasive diagnostic procedure is recommended. Current risk/benefit analyses indicate that shunt operations improve outcome compared to the spontaneous course of the disease. CONCLUSION: Normal pressure hydrocephalus should always enter into the differential diagnosis of patients who present with its characteristic manifestations. If the diagnosis of NPH is confirmed, it should be treated at an early stage.
Authors: Matthew J McGirt; Graeme Woodworth; Alexander L Coon; George Thomas; Michael A Williams; Daniele Rigamonti Journal: Neurosurgery Date: 2005-10 Impact factor: 4.654
Authors: S Pujari; S Kharkar; P Metellus; J Shuck; M A Williams; D Rigamonti Journal: J Neurol Neurosurg Psychiatry Date: 2008-03-20 Impact factor: 10.154
Authors: H Schmidt; J Elster; I Eckert; J Wiefek; W Paulus; N von Steinbuechel; E N Abatih; J Blocher Journal: J Neurol Date: 2014-09-20 Impact factor: 4.849
Authors: M Ivkovic; B Liu; F Ahmed; D Moore; C Huang; A Raj; I Kovanlikaya; L Heier; N Relkin Journal: AJNR Am J Neuroradiol Date: 2012-12-20 Impact factor: 3.825
Authors: Benjamin C Reeves; Jason K Karimy; Adam J Kundishora; Humberto Mestre; H Mert Cerci; Charles Matouk; Seth L Alper; Iben Lundgaard; Maiken Nedergaard; Kristopher T Kahle Journal: Trends Mol Med Date: 2020-01-18 Impact factor: 11.951